STAT3 and renal cell carcinoma: This study showed that a high MCPIP1 level decreased the phosphorylation of the c-Met receptor, Src kinase, and the transcription factor STAT3 in RCC cells, even after the acquisition of sunitinib and sorafenib resistance.